We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+27.44%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$6.27B
AUM Growth
+$1.32B
Cap. Flow
+$81.3M
Cap. Flow %
1.3%
Top 10 Hldgs %
29.27%
Holding
150
New
7
Increased
71
Reduced
48
Closed
5

Top Buys

Rank Stock Value
1
VERX icon
Vertex
VERX
+$70M
2
MODN
MODEL N, INC.
MODN
+$45.2M
3
CWST icon
Casella Waste Systems
CWST
+$18.2M
4
SLP icon
Simulations Plus
SLP
+$14.1M
5
AVLR
Avalara, Inc.
AVLR
+$6.87M

Top Sells

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$42.1M
2
PRLB icon
Protolabs
PRLB
+$36.3M
3
RGEN icon
Repligen
RGEN
+$26.1M
4
WDFC icon
WD-40
WDFC
+$11.2M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$8.43M

Sector Composition

Rank Sector Weight
1 Technology 33.67%
2 Industrials 28.38%
3 Healthcare 17.2%
4 Consumer Discretionary 8.25%
5 Materials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACIW icon
26
ACI Worldwide
ACIW
$5.42B
$116M 1.86%
3,028,612
+31,704
+1% +$1.06M
MMSI icon
27
Merit Medical Systems
MMSI
$5.32B
$115M 1.83%
2,064,818
+18,573
+0.9% +$959K
MODN
28
DELISTED
MODEL N, INC.
MODN
$112M 1.78%
3,133,031
+1,305,671
+71% +$45.2M
RP
29
DELISTED
RealPage, Inc.
RP
$108M 1.72%
1,240,565
-65,457
-5% -$4.29M
BCPC
30
Balchem Corp
BCPC
$5.72B
$108M 1.72%
939,134
+7,458
+0.8% +$787K
EPAY
31
DELISTED
Bottomline Technologies Inc
EPAY
$103M 1.63%
1,944,661
+13,398
+0.7% +$609K
JBTM
32
JBT Marel
JBTM
$6.39B
$100M 1.6%
880,655
+8,907
+1% +$919K
ESE icon
33
ESCO Technologies
ESE
$7.92B
$98.6M 1.57%
955,281
+3,482
+0.4% +$328K
VERX icon
34
Vertex
VERX
$1.94B
$89.6M 1.43%
+2,572,160
New +$70M
LOPE icon
35
Grand Canyon Education
LOPE
$3.98B
$88.9M 1.42%
954,608
+8,812
+0.9% +$752K
QTWO icon
36
Q2 Holdings
QTWO
$3.92B
$77.9M 1.24%
616,031
+9,461
+2% +$1.02M
DORM icon
37
Dorman Products
DORM
$4.18B
$77.4M 1.23%
891,294
+5,941
+0.7% +$551K
LMAT icon
38
LeMaitre Vascular
LMAT
$1.86B
$76.7M 1.22%
1,893,192
+9,153
+0.5% +$327K
FIVN icon
39
FIVE9
FIVN
$2.54B
$76.5M 1.22%
438,803
+1,088
+0.2% +$165K
TECH icon
40
Bio-Techne
TECH
$11.3B
$76.1M 1.21%
959,028
-581,176
-38% -$42.1M
HLIO icon
41
Helios Technologies
HLIO
$2.76B
$73.7M 1.17%
1,382,887
+9,290
+0.7% +$437K
LGND icon
42
Ligand Pharmaceuticals
LGND
$6.36B
$71.3M 1.14%
1,148,453
+11,288
+1% +$644K
ROG icon
43
Rogers Corp
ROG
$2.4B
$66.4M 1.06%
427,319
+2,469
+0.6% +$327K
OFLX icon
44
Omega Flex
OFLX
$312M
$63.9M 1.02%
437,749
+2,643
+0.6% +$417K
CMD
45
DELISTED
Cantel Medical Corporation
CMD
$62.9M 1%
797,481
+8,327
+1% +$488K
WDFC icon
46
WD-40
WDFC
$3.15B
$62.8M 1%
236,505
-46,102
-16% -$11.2M
EVI icon
47
EVI Industries
EVI
$180M
$31.6M 0.5%
1,056,212
+20,709
+2% +$635K
POOL icon
48
Pool Corp
POOL
$7.5B
$31.1M 0.5%
83,588
+4,260
+5% +$1.49M
NRC icon
49
NRC Health Common Stock
NRC
$450M
$29.6M 0.47%
691,268
+16,474
+2% +$846K
ROL icon
50
Rollins
ROL
$18.2B
$28.2M 0.45%
721,168
-54,700
-7% -$2.12M
1
2
3 4 5

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

Conestoga Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Conestoga Capital Advisors held 150 positions worth $6.27B, up 27% from $4.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors's Q4 2020 filing shows 7 new, 71 increased, 48 reduced and 5 closed positions. Its largest new stake was Vertex: 2,572,160 shares worth $89.6M. The largest sale was Bio-Techne, an estimated $42.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Conestoga Capital Advisors's largest Q4 2020 buy was Vertex: 2,572,160 shares worth $89.6M.
  • Conestoga Capital Advisors added most to MODEL N, INC. in Q4 2020, an estimated $45.2M increase.
  • Conestoga Capital Advisors's biggest Q4 2020 reduction was Bio-Techne, cutting an estimated $42.1M.
  • Conestoga Capital Advisors fully exited Protolabs in Q4 2020, selling an estimated $36.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $6.27B portfolio in Q4 2020.
  • Conestoga Capital Advisors opened 7 new positions and closed 5 in Q4 2020.
  • Conestoga Capital Advisors's portfolio value rose 27% quarter-over-quarter to $6.27B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2020, filed 26 Jan 2021.